CAGE1 and neoplasm: It was shown in vivo that the CAR vector containing the single-chain variable fragment (CT3), CD28 hinge and transmembrane and 4-1BB domain (CT3.28H.BBζ) showed the most optimum antitumour effects, and the tumour regressed after 4 weeks of CAR T-cell infusion [53].